# How Do Health Systems Calculate Prior Authorization ROI in 2026?

hcco.app · September 27, 2026

> Direct Answer: What Counts as Prior Authorization ROI? Prior authorization ROI is the measurable financial and operating value created by reducing...

## Direct Answer: What Counts as Prior Authorization ROI?

Prior authorization ROI is the measurable financial and operating value created by reducing avoidable approval work, accelerating clinically appropriate treatment, and lowering denial-related rework—after accounting for software, labor, implementation, and compliance costs. A credible calculation compares a defined baseline period with a comparable post-deployment period and adjusts for changes in authorization volume, staffing, payer mix, service lines, and case complexity. The strongest business cases usually track dollars spent, staff hours consumed, turnaround time, denial rates, and outcomes that matter to patients and clinicians. A platform that merely counts tasks automated has not established ROI; work completed is a more useful unit than clicks, messages, or AI-generated recommendations. For a 2026 evaluation, health systems should expect prior authorization to remain important even as UnitedHealthcare’s announced elimination of prior approval requirements for approximately 1,700 treatments shows that policy scope is changing. The correct question is not whether every authorization needs software, but which remaining requests create enough delay, labor, or rework to justify intervention.

**Also worth reading:** [How Do Prior Authorization Workflow Tools Work for Payers and Providers in 2026?](https://hcco.app/knowledge/how_do_prior_authorization_workflow_tools_work_for_payers_and_providers_in_2026.php) · [How Ready Is Your Organization for the 2027 CMS Prior Authorization Requirements?](https://hcco.app/knowledge/how_ready_is_your_organization_for_the_2027_cms_prior_authorization_requirements.php) · [What Are the CMS Prior Authorization Standards, and Who Must Comply by 2027?](https://hcco.app/knowledge/what_are_the_cms_prior_authorization_standards_and_who_must_comply_by_2027.php)

## How to Build a defensible ROI model

Start by defining authorization categories because a model spanning surgical procedures, imaging, medications, behavioral health, and post-acute services will not have a meaningful average. Segment the baseline by payer, service line, urgency, request channel, and submission method, then select a period with stable volumes. Measure minutes per request from intake through final disposition, including status calls, fax handling, clinical documentation, peer-to-peer review, correction, and appeal work. Multiply reviewed time by fully loaded hourly cost rather than billing rate alone, because ROI calculations that omit benefits, payroll taxes, management time, and vacant-seat costs can materially overstate savings. For example, 20 minutes saved per request at a fully loaded $45 hourly cost produces $15 in gross labor value per case, or $150,000 across 10,000 cases, before platform and implementation expenses. The baseline must also include avoided denials and patient delay, but those benefits need probability-based estimates rather than automatic dollar claims.

A practical formula is annualized gross benefit minus total cost of ownership, divided by total cost of ownership. If a program generates $480,000 in annual labor value, $70,000 in measured rework reduction, and $50,000 in reasonably attributable avoided denial cost, while annual operating and implementation costs are $300,000, first-year ROI is 100 percent: $300,000 net value divided by $300,000 cost. A mature run-rate calculation can exclude one-time implementation but must not omit ongoing integration, model monitoring, security review, and human oversight. Teams should report payback period alongside ROI because a high-return program with a 30-month payback may be less attractive than a lower-return program recovering its cost in eight months. Confidence intervals or sensitivity ranges are also appropriate when authorization volumes, denial probabilities, or savings realization remain uncertain.

## What financial and operational metrics should be included?

Labor savings are usually the most immediate ROI category, but they are not automatically cash savings. A reduction from 30 minutes to 18 minutes per case saves 12 staff-minutes, yet that value becomes actual cost reduction only if overtime, contract labor, hiring plans, or departmental capacity changes. Track request volume, touch count, first-pass completeness, average and 90th-percentile turnaround, staffing hours per authorization, denial rate before appeal, appeal overturn rate, and time to treatment. A 15 percent reduction in administrative time is meaningful only alongside stable or improved turnaround and clinical service levels. Patient access metrics can include abandonment rates, days from request to decision, and the interval between approval and scheduled care, although the last measure can be affected by unrelated scheduling constraints.

Denial and revenue-cycle effects deserve separate treatment. A prevented denial is valuable only if the payer otherwise would have denied the claim and the organization can document the expected write-off or collection delay. One should not add gross charge amounts to the ROI model as though every prevented denial produces equivalent cash. Instead, use expected net collectible revenue, appeal expense, and the probability that an intervention changes the final outcome. For a $25,000 account with an 80 percent expected collection rate, assigning the entire charge to a prevented denial would overstate value by $5,000 even before considering allowable amounts. Some organizations also assign a patient-experience value, but that should remain separate from hard ROI unless the organization has a validated willingness-to-pay or approved internal metric.

| ROI component | Conservative method | Stronger method | Common overstatement |
| --- | --- | --- | --- |
| Staff time | Minutes removed multiplied by loaded hourly cost | Realized overtime, contractor, or hiring impact | Counting all saved minutes as immediate cash |
| Denials | Actual avoidable denials and verified write-offs | Risk-adjusted, payer-specific expected value | Treating gross billed charges as recovered cash |
| Turnaround | Median change in decision time | Median plus 90th percentile and urgent-case performance | Averaging together unlike service lines |
| Patient access | Fewer abandoned requests or shorter treatment delays | Measured downstream effect on care start | Claiming every scheduling delay was authorization-related |
| Software value | Net benefit divided by total cost | Net benefit under base, low, and high scenarios | Reporting task counts instead of completed work |

## How automation and AI affect the calculation
Automation can create value by collecting missing documentation, routing requests, checking payer rules, preparing standardized responses, and reducing repetitive portal or fax work. It should not be credited for merely generating a draft that staff must extensively rewrite, or for marking a request “processed” without obtaining a decision. The HIT Consultant research context specifically argues that healthcare AI ROI should be measured by work completed rather than tasks automated, which is particularly important for prior authorization because a completed authorization still requires a valid decision, accurate coding, and timely communication to the care team. AI may improve throughput but create review burden if it hallucinates clinical evidence, omits a payer-specific criterion, or changes the meaning of submitted documentation. Human review is therefore a cost or risk-control requirement, not evidence that automation has failed.

The strongest evaluation compares an assisted group with a control or phased rollout where feasible. For a 12-month program, at least three months of baseline and three months of post-launch data can reveal directional change, but six to twelve months is preferable when seasonality, payer policy changes, and staffing turnover matter. Johns Hopkins’ reported use of ambient AI to reduce burnout and streamline prior auth illustrates the connection between administrative relief and clinical operations, yet a burnout reduction should not be monetized without a defensible method. A health system might report staff survey changes and time reclaimed while keeping those benefits outside the conservative financial ROI. This separation makes the business case easier to audit and prevents soft benefits from hiding weak economics.

## Practical steps for a payer or provider operations team

First, select one high-volume authorization workflow and establish a data dictionary before purchasing software. Define what starts and stops the clock, identify every human touch, and reconcile the operational system with the enterprise authorization platform and claims data. A six- to eight-week baseline may be sufficient for a narrow pilot, while a 12-month lookback is better for volatile categories. Next, calculate current cost per completed authorization, including staff time and rework, and determine the median, 90th percentile, denial rate, and channel mix. These values become the comparison point; percentages alone are not enough because a 20 percent improvement on 2,000 annual cases may matter less than a 10 percent improvement on 100,000.

Then define pilot success thresholds before deployment. A reasonable starting point is at least 15 percent lower touch time, no increase in denial or appeal rates, and a 20 percent reduction in median turnaround for the targeted workflow. These are management thresholds, not universal healthcare standards, and they should be adjusted for case complexity and payer behavior. Validate integration capabilities, audit logging, role-based access, encryption, retention policies, vendor security evidence, escalation paths, and the treatment of protected health information. During the pilot, sample completed cases weekly and compare staff effort, decision accuracy, and exception handling with the baseline. Finance should verify which labor savings are likely to become budget reductions; operations should confirm that clinicians can spend the time returned on patient care rather than absorbing additional documentation elsewhere.

## Alternatives, build-versus-buy decisions, and cost expectations

The main alternatives are staffing optimization, rules-based workflow improvement, outsourced prior authorization services, a payer portal, an enterprise authorization platform, or a focused SaaS product integrated with existing systems. Staffing and process redesign are often necessary even with software, particularly when the real problem is unclear ownership or poor documentation. Outsourcing can convert variable labor expense into a per-case fee and may provide 24-hour coverage, but it does not eliminate all internal oversight or continuity risk. A broad enterprise platform may offer stronger governance and payer connectivity, while a focused SaaS product may deploy faster and prove value in one workflow more readily. Neither architecture is inherently superior; total cost, integration burden, workflow fit, and measurable outcomes decide the choice.

Pricing is rarely comparable across these options. Staffing costs depend on local wages and qualification mix, outsourcing is commonly priced per authorization or volume tier, and SaaS may combine subscription, implementation, interface, usage, support, and validation fees. As of September 2026, buyers should not accept an undefined “AI included” claim as a cost model. Request a year-one and year-two total-cost schedule, implementation duration, required infrastructure, overage rules, renewal caps, termination fees, and the cost of validating clinical or payer-rule changes. Calculate breakeven by dividing annual gross benefit by annual avoidable cost, but also ask whether the vendor can substantiate the value with its customers. A product that costs $250,000 annually needs $250,000 in verified benefit to break even; if only half of its expected benefit is labor capacity that the organization can actually remove, the true return may be far lower than the demonstration suggests.

| Approach | Typical cost structure | Best use | Main limitation |
| --- | --- | --- | --- |
| Process redesign | Internal labor and training expense | Broken handoffs, unclear ownership | May not scale across payer and service-line variation |
| Outsourcing | Per-case, per-transaction, or minimum-volume fees | Variable volume and around-the-clock coverage | Less internal control and possible duplicate effort |
| Enterprise platform | Subscription, modules, implementation, and enterprise integrations | Multi-workflow governance | Higher cost and longer deployment |
| Focused SaaS | Subscription plus implementation, usage, and integration fees | A high-volume, well-defined workflow | Narrower platform scope and vendor dependence |
| Internal build | Engineering, clinical validation, data, maintenance, and support | Differentiated logic or strict integration control | High opportunity cost and long-term maintenance burden |

## Common mistakes that inflate or conceal ROI
The most common mistake is using authorization-request counts without measuring completed, payable decisions. Another is comparing a low-volume pilot month with a peak baseline month, which can make ordinary growth appear to be automation gains. Teams also tend to mix payer policy changes with product performance; for example, a payer eliminating prior approval for 1,700 treatments would change volume and case mix even if the software did nothing. Double counting occurs when labor savings, avoided denials, and faster treatment all represent the same underlying case. Finally, omitting failed submissions, manual exception queues, audit sampling, integration maintenance, and security compliance makes the operating cost look artificially low.

A second group of errors concerns benefits that are plausible but unverified. Treating clinician time as a cash saving is acceptable only if capacity changes are observable. Assigning dollar value to reduced burnout without a validated conversion method is less defensible, as is using patient satisfaction changes as a direct ROI line. Relying on a vendor’s average customer result also requires normalization by authorization type, geography, payer contracts, and baseline maturity. Independent sampling should test whether submitted evidence actually supports the request and whether approved services are correctly communicated. A 30 percent drop in turnaround is not positive if 10 percent more cases receive inaccurate decisions or require appeals. ROI must therefore include quality and compliance guardrails, not just efficiency.

## When to act, scale, pause, or stop

A program is ready to expand when it demonstrates repeatable savings across several comparable cohorts, not merely one unusually efficient site. A practical gate is positive net benefit at conservative assumptions, payback within the organization’s approved limit, and no material deterioration in denial, appeal, accuracy, or patient-access metrics. Many teams use a target payback below 18 to 24 months, but the appropriate threshold depends on the size and strategic tolerance of the investment. Scale first in workflows with stable rules and high transaction volume, then tackle clinically complex or low-volume requests where automation economics may be weak. Review results at 30, 60, 90, and 180 days, with additional checkpoints after payer-policy or EHR changes.

Pause expansion if the vendor cannot provide complete audit trails, staff must bypass the tool frequently, or the pilot shifts work into a larger downstream queue. Stop or redesign a program if savings disappear after stabilization, if denied cases increase without explanation, or if the total cost of exceptions exceeds contracted fees. Some requests should never be automated indiscriminately: urgent cases, nuanced therapies, incomplete records, and situations requiring peer clinical judgment need clear escalation. The right strategic outcome is not maximum automation; it is the least costly combination of people, process, and technology that produces accurate decisions quickly. As payer policies continue narrowing authorization requirements through 2026, organizations should revisit the addressable volume regularly rather than locking capital expenditure assumptions to today’s process.

## Quick answers

### What is the fastest way to estimate prior authorization ROI?

Multiply avoidable minutes per completed authorization by fully loaded hourly labor cost, then add verified rework and denial effects. Subtract software, implementation, integration, oversight, and maintenance costs, and report a conservative range if savings realization is uncertain.

### Is a reduction in prior authorization turnaround time always ROI?

No. Faster turnaround is beneficial when it reduces avoidable clinical or administrative delay, but speed alone does not prove financial value. It should be evaluated alongside labor, denial, patient-access, quality, and compliance measures.

### How long should a prior authorization automation pilot run?

A narrow pilot may show directional results in six to eight weeks, while a three-to-twelve-month baseline and follow-up period is better for claims about ROI. Longer evaluation is useful when volumes, payer policies, staffing, or case complexity vary seasonally.

### Should ROI include reduced staff burnout?

Burnout reduction can be reported as an operating benefit, but assigning it a dollar value requires a transparent, validated methodology. Conservative financial cases often keep burnout findings outside hard ROI until the organization can show realized staffing, turnover, or capacity effects.

### Can prior authorization software replace authorization staff?

Software usually changes the staffing model rather than simply eliminating the role. Exception handling, clinical review, payer policy interpretation, audits, escalations, and patient communication still require accountable people, although automated intake and routing may reduce repetitive work.

Canonical: https://hcco.app/knowledge/how_do_health_systems_calculate_prior_authorization_roi_in_2026.php
Markdown: https://hcco.app/knowledge/how_do_health_systems_calculate_prior_authorization_roi_in_2026.php/index.md